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S T U D I E S ON S E R U M ZINCEMIA IN 202 PERSONS 
W I T H POSTHEPATITIC SYNDROMES AND AFFECTIONS 
A. Minkov, AI. Stanchev 
Zinc is an element playing an important role in intermediate metabo-
l ism, owing to its relationship to the active center of a number of ferments 
(2) . Th i s was demonstrated in a clearcut manner after K e i l i n and Mann 
(1944) succeeded in isolating carbonic anhydrase in 1944 and established 
that it contains 0.33% zinc, and after Val lee and co-workers discovered 
zinc in some dehydrogenases, peptidases, transphosphorilases and the l ike 
(32, 33). S i m i l a r l y , it has been long since pointed out that distribution of 
zinc in the various organs is regulated by the l iver (Shelline, Chaikoff and 
assoc. 1943, cited by 25). E v e r since then, intense studies on the zinc meta-
bolism in various hepatic diseases was begun. I t has been found out that 
virus hepatitis (vh) runs a course wi th transitory lowering of zinc concen-
tration in the whole blood (1) and serum (3, 18, 25, 38). Any way, there are 
reports on investigations by other authors in which a s imilar reduction has 
not been established (4). I n the urine of vh patients, an increased (1), or 
normal zinc content (3) has been found. The zinc level in the l iver of v h 
patients is reduced, some times up to 2—2.5 times that of the normal (22). 
During the healing stage, the normalization of zinc in the blood and urine 
lags behind the normalization of some of the laboratory indices (1) . The 
slow normalization of the serum zinc is explained by the deep alteration 
of some of the l iver functions. I t was established that in alcoholic and post-
hepatitis cirrhosis the zinc concentration in the serum decreases (4, 24, 25, 
26, 36, 37, 38), whereas the zinc amount eliminated v i a 24-hour urine is 
increased, sometimes quite significantly (4, 24, 27, 36). The zinc content 
in the cirrhotic l iver is low (10, 13, 15, 20, 2 1 , 22, 24, 25, 26, 29, 34, 35, 36 
and others). Val lee and co-workers established that there is a correlation 
between the c l in ica l picture of cirrhosis, resp. its early or advanced phase, 
and the decrease of zinc in the serum, resp. its rise in the urine (29, 34, 35, 
36) . The hepatic coma is accompanied by very strong reduction of the serum 
zinc (according to 4 ) . 
Based on the facts referred to above, we investigated the serum concen-
tration of zinc in subjects w i th past illness of v i rus hepatitis and compared 
the results wi th the subjective and objective symptoms and wi th the cl inico-
laboratory indices of those investigated. The purpose was to see if in the 
various groups of the total number of affected wi th vi rus hepatitis in the 
past (e. g. cured, w i th chronification of the process, cirrhoses) there are 
changes in the serum zinc, and up to what extent would they be considered 
as an additional index in evaluating the curing, respectively chronification 
of the condition. The present report is a continuation of earlier investiga-
tions by the same authors (5, 6) . 
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Material and Method 
A series of 202 persons wi th past history of virus hepatitis, dating back 
6 months to 20 years, were investigated. The age of the patients ranged from 
5 to 78 years, wi th a net predomination of the cases in the 25—50 years 
age group. The males were 100 and the females — 1 0 2 . The investigations 
were made on the basis of 26 subjective, 15 objective (physical) and 33 c l i -
nico-laboratory indices. According to the results recovered, the total num­
ber was divided into 6 groups, in accordance to the overall assessment of 
the l iver after the affection: 
1) Cured — 9 2 cases 
2) Not cured ( i . e. w i th protracted process) — 4 7 cases. 
3) Isolated residual hepatomegaly («fibrosis», «chronic inactive hepa-
t i t is», without evidence for ac t iv i ty of the process) — 2 2 cases. 
4) Posthepatitis hyperbilirubinemia (PHHB) — 5 cases. 
5) Chronic hepatitis — 2 7 cases. 
6) Posthepatitis cirrhosis — 9 cases. 
Biopsy diagnosis was established in isolated cases only. 
The serum zinc was demonstrated according to the dityson method of 
Rechenberger. The mean zincemia established in 22 healthy persons amounted 
to 1 3 2 ± 2 3 gamma % at M = 4 . 9 . We assumed that zincemia decrease was 
present whenever its concentration was beneath 109 gamma %. 
Results. The overall results of the investigation of zinc in the series 
of 202 cases wi th past history of virus hepatitis, distributed in the 6 groups, 
are the following: (Table 1). 
T a b l e 1 
Results of zinc level investigations in 202 individuals with past virus hepatitis illness 
Group Cases Reduced zinc Normal zinc 
Mean zinc concen­
tration у % 
1. Cured 
2. Uncured 
3. Residual Hepatomegalia 

















5. Chronic hepatitis 









The lowest value substantially beneath the normal zincemia — 7 1 gam­
ma % — is noted in cirrhosis. Next, s imi la r ly wi th low mean zincemia — 
104 gamma % — i s the group of chronic hepatitis. The above figures are 
s tat is t ical ly reliable as compared to the group of cured, as wel l as between 
each other. I n the remaining 4 groups ( 1 , 2, 3 and 4) , the mean zinc con­
centration is wi th in normal l imits , and in isolated cases —above the norm. 
Groups 2, 3 and 4 did not show stat is t ical ly reliable zinc reduction as rela­
ted to group 1 — t h e cured, and between each other neither. 
Group 1. We assumed as cured the cases which, after the vh illness, were 
free of subjective and objective signs for hepatic disorders and revealed 
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normal clinico-laboratory indices of the condition of the l iver . The mean 
serum zincemia in the group, comprising 92 investigated subjects, was 
wi th in the normal l imits — 126.22 gamma % . I n 25 cases the zincemia 
was between 87 and 106 gamma % (27 .1%) , and in the remainder (67) — 
the zincemia was normal or sl ightly exceeding the norm. The time elapsed 
after the acute affection in 25 cases w i th reduced zinc was between 0.5 and 
11 years, and in the 67 cases wi th normal zinc —between 0.5 and 
13 years. 
Group 2. We assumed as U N C U R E D acute hepatitis cases those which 
after the s ix th month and before the second year from the acute stage of the 
disease, have usually insignificant subjective complaints, without or wi th 
but slight hepatomegaly, and wi th one to three clinico-laboratory indices 
for hepatic damage (urobilinogenuria, hypergammaglobulinemia, increased 
Weltmann's column or pathological MacLagan test). The mean serum zin-
cemia of the 47 subjects investigated from this group was normal — 125 
gamma % . Decrease of zinc was recorded in 17 cases (36 .1%) , the concen-
tration ranging from 70 to 106 gamma % . I n the remainder (30 cases), the 
zincemia ranged between 110 and 225 gamma %. No dependence was estab-
lished between the degree of zincemia and the results of the routine indices 
for hepatic lesion. 
Group 3. I t includes the cases in which a certain, more frequently insig-
nificant hepatomegaly is established after the second year from the onset, 
without or in single cases, w i th insignificant symptomatics (usually slight 
pains or heaviness in the region of the l iver following physical s train) , and 
in most of the patients, w i th lack of even one pathological, clinico-labora-
tory index. Out of 22 subjects investigated, a decreased zinc was noted in 
9 (40 .9%) , wi th zinc fluctuations from 74 to 106 gamma % . Normal zinc was 
recorded in 13 cases (between 115 and 225 gamma % ) . The mean zincemia 
for the group amounted to 128.22 gamma %. 
Group 4. Out of the five persons investigated wi th posthepatitis hyper-
bilirubinemia, reduced zinc values were established in two cases (76 and 
106 gamma % ) . 
Group 5. The group of chronified hepatitis comprised 27 subjects. Their 
vh illness dated back more than 2 years ago. A l l exhibited pronounced 
subjective symptomatics, hepato-, spleno- or hepatosplenomegaly, plus 
more than three pathological results of the laboratory indices, considered 
most important for chronic hepatic damage (urobilinogenuria, hypergam-
maglobulinemia, hyperbilirubinemia, hypoalbuminemia, positive f lobu-
lation reactions). The serum zinc was found to be reduced in 21 of the 27 
persons investigated (77 .7%) . The zincemia concentration ranged from 60 
to 108 gamma % . 
We failed to establish an interdependence between zincemia, on the 
one hand, and duration of the disease, subjective complaints, objective 
symptoms and laboratory tests, on the other. 
S i x of the patients disclosed normal zincemia — from 135 to 177 gamma % . 
These patients did not differ significantly from the other 21 cases wi th 
reduced zinc, neither in terms of duration of the affection, nor in terms of 
symptomatology presented. The most frequently met wi th c l in ica l and 
clinico-laboratory indices in the group of 27 patients are illustrated in 
Table 2. 
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T a b l e 2 
The most frequently met clinical and clinico-laboratory indices 
in 27 patients with chronic hepatitis 
Indices Cases 
1. Subjective complaints 




6. MacLagan reaction above 40 PhU 
7. Hypergammaglobulinemia (above 23%) 
8. Hyperbilirubinemia 
9. Icterus on the skin or sclera 
10. Splenomegalia 
11. Anemia (Hb beneath 70%) 
12. Increased transaminases 
13. Leukopenia (leuk. beneath 5000) 



















T a b l e 3 
I t is evident from the table that in chronic hepatitis, the hypozincemia 
is inferior in terms of frequency of the subjective symptoms, increased 
Weltmann's column, hepatomegaly and hyperurobilinogenuria, and exceeds 
in terms of incidence of such 
important indices as the Mac-
Lagan reaction, hypergammaglo-
bulinemia, splenomegaly and 
hyperbil irubinemia. 
Group 6. I t comprises 9 cases 
wi th posthepatitis cirrhosis, 8 of 
which in advanced stage (5 wi th 
ascites). The zinc was decreased 
in 8 cases (88 .8%) , exhibi t ing 
a fluctuation between 25 and 
Dependence between Zincemia and 




lins % Zinc y % 
1. M. P. M. 43 25 
2. T . M. K . 40 54 
3. H . N. A. 36.3 86 
4. M. D. M. 30.8 80 
5. B . Y . M. 28 141 
6. N. N. P. 27.5 58 
7. Y . E . Z. 26.3 70 
8. T. S. T. 24 80 
9. S. D. S. 20 45 
141 gamma % . The mean zince-
mia of the group amounted to 
71 gamma % . The lowest z inc 
values — 2 5 and 45 gamma% — 
were recorded in patients w i th 
greatly advanced, ascitic stage, 
w i t h hepato- and splenomegaly, 
large gynecomastia in one of 
them and length of the postacute stage of the disease ranging from 4 to 20 
years. The only patient wi th normal zincemia (141 gamma % ) concerned 
a gi r l wi th ascites and duration of vh 6 months. 
No strict interdependence was established between the degree of z in-
cemia and the other c l in ica l and clinico-laboratory indices. A certain de-
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gree of correlation was however discovered between hypozincemia and 
hypergammaglobulinemia (Table 3 ) . 
The incidence of hypozincemia wi th posthepatitis cirrhosis in our se-
ries came after the subjective complaints, hyperurobilinogenuria, increased 
T a b l e 4 
The most frequently met clinical and clinico-laboratory 
indices in 9 patients with posthepatitis cirrhosis 
Indices Cases 
1. Subjective complaints 9 
2. Hyperurobilinogenuria 9 
3. Weltmann reaction above 7 test-tubes 9 
4. Hyperbilirubinemia 9 
5. Hypozincemia 8 
6. MacLagan reaction above 40 PhU 8 
7. Hypergammaglobulinemia 8 
8. Hypoalbuminemia (alb. beneath 55%) 7 
9. Hepatomegalia 7 
10. Telangiectasis 7 
11. Emaciation 7 
12. Ascites 6 
13. Anemia (Hb beneath 70%) 6 
14. Palmar erythema 5 
15. Splenomegalia 5 
16. Leukopenia (leuk. beneath 5000) 4 
17. Icterus on the skin or sclera 3 etc. 
I 
Weltmann's column and hyperbil irubinemia, recorded in the 9 cases. Hy-
pozincemia was established as often as the pathological reaction of Mac-
Lagan and hypergammaglobulinemia — i n 8 of the nine cases (Table 4 ) . 
Discussion and Inference 
Among the group of persons wi th past history of virus hepatitis, there 
was not a single case wi th evidence for pancreatic, renal, infectious, neo-
plastic, blood or other diseases which are known to cause occasionally, a 
decrease of the serum zinc. Hence, the low values of zinc in our series should 
be explained by a process developing in the l iver . We can't make a defini-
t ive statement that the 6 groups, differentiated in the present study, com-
prise only the diagnoses referred to the respective groups. Exceptions are 
by a l l means possible, since the biopsy of the l iver has not been routinely 
and regularly done. Nevertheless, we have strived towards a long-term and 
cr i t i ca l re-evaluation of the diagnoses (secondary follow-up examinations 
of a great number of patients), on the basis of the overall c l in ica l and labo-
ratory finding concerning the hepatic state in each individual case. 
F rom the data obtained, it is obvious that the cases wi th hypozincemia 
show a steady rise, to begin wi th the group of cured where they amount 
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to 27% and passing to the group of not cured — 3 6 % , wi th residual hepa-
tomegaly — 40%, chronic hepatitis — 7 7 % and f inal ly , reaching the 
group wi th posthepatitis cirrhosis, where the hypozincemia cases show the 
highest percentage — 8 8 % ( F i g . 1). 
The second fact worth noticing is that the lower l imi t of the hypozin-
cemic values reveals a progressive fall in the direction from group I to group 
V I — accordingly 87, 70, 74, 60, 60 and 25 gamma % ( F i g . 1). 
A third circumstance, although not so obvious, owing to the small num-
ber of observations, is that certain conformity was established between the 
degree of hypozincemia and the rise of gammaglobulin fraction in the serum, 
part icularly in group V I (Table 3) . I n this respect, we would l ike to quote a 
s imi la r find ng made by Wolf (38), in the course of personal investigations. 
I t might be assumed that insofar as the progressive rise of hypergamma-
globulinemia is considered as an important index about chroniiication and 
cirrhogenic processes in the l iver , the steady reduction of the serum zin-
cemia, in the course of months and years after the vh illness, is also (pro-
bably) one of the symptoms characteristic of these processes. I n this res-
pect we would add also the correlation established between hypozincemic 
values in these cases and the hyperurobilinogenuria and increased Welt-
mannes reaction etc in groups 5 and 6. 
The finding of progressive reduction of the dynamical ly traced up z in-
cemia is, in a l l likelihood, an additional indication that the process in the 
l iver is not discontinued, but on the contrary, it persists and progresses 
wi th the eventual possibility of developing cirrhosis which is characterized 
by the lowest serum zinc concentrations known hitherto. 
Our data demonstrate that the normalization of zincemia after vh con-
stitutes a rather inert, slow process. The practical curing of hepatitis, a l -
though in a l imited number of cases, might be associated, for some period 
of time, wi th a sl ightly reduced zincemia. S imi l a r inferences have been 
reached by other authors also (3). I n this respect, the sluggish dynamics 
of zincemia is in contrast to its prompt alteration observed in patients in the 
reconvelescent, postcoronary infarction period (7) and suggests the possi-
b i l i ty for the existence of various mechanisms of changes. 
The item of the essence of the mechanisms through which chronic hepa-
topathies lead to decrease of the zinc level in the serum and in the hepatic 
tissue is scarcely investigated and for the time being we do not ava i l of an 
acceptable explanation. 
More investigations have been made on the influence of alcohol upon 
the zinc-metalloenzymes in the l i v e r — a l c o h o l dehydrogenase, glutamate 
dehydrigenase etc —as well as wi th the purpose to find an explanation of 
the paucity of zinc loss in the hepatic tissue in alcoholic cirrhosis (11 , 26, 
29, 30, 34). The chronic alcoholic intoxication causes a reduction of the 
ac t iv i ty of alcohol dehydrogenase in the l iver (11 , 26). I t is possible that 
detachment of the zinc ion from the active center of the ferments is con-
cerned, wi th intense discharge of zinc in the urine and fall of the serum and 
tissue zinc level . 
Rechenberger and co-workers (24, 25) presume that the reduced zinc 
content in the serum in cirrhosis is a manifestation of systemic affection of 
the zinc metabolism, subsequent to the cirrhogenic lesion of the hepatic 
parenchyma, resulting in the occurrence of a negative zinc balance. 
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Others, doubtful of the alcohol effect upon zinc-metalloenzymes, assume 
that the rising dysproteinemia in the course of hepatopathies might cause 
a defect in the zinc-binding capacity of the plasmatic and tissue proteins, 
which in turn, might lead to disorder in the zinc balance of the organism 
(15, 18). 
The studies in this respect are rendered rather difficult as the zinc in 
the blood is not bound to a specific protein carrier. Zinc fractions in the 
blood are known, carried by the albumins, a l p h a b a lpha 2 , beta!, beta 2 and 
gamma globulins (9). F i r m l y bound zinc exists — about 34%, probably, 
as a zinc-proteid of alpha-1 and alpha-2 globulins, and labile bound zinc — 
about 66%, carried by the albumins and beta-globulins (4). 
Reports on studies on the causes of the organism getting poor in zinc 
content subsequent to vh affection were not found in the pertinent litera­
ture. I t is a well known fact that some of the zincmetalloenzymes during 
vh affection, exhibi t higher ac t iv i ty in the blood, such as glutamate dehyd­
rogenase, which normally is not found in the blood, lactate-lactic dehydro­
genase and others. 
I n general outline, the metabolism of zinc in parenchymal lesions of the 
l iver (hepatitis, cirrhosis) reveals certain characteristic features, distin­
guishing it from the metabolism of the other metals. For instance, copper 
in vh (8) and in cirrhosis is increased in the serum, and in cirrhosis — in 
the l iver too, iron in vh is increased in the serum and lowered in the liver,, 
and in cirrhosis it is reduced in the serum and increased in the l iver , magne­
sium is decreased in the serum in alcoholism and cirrhosis (12, 19, 28), and 
increased in renal insufficiency (14) and so on. On the contrary, in acute 
and chronic hepatic parenchymal diseases, a total impoverishment of zinc 
is observed, involving the serum, hepatic tissue and sweat secretion (23), 
associated wi th concomitant increased urinary discharge rate. 
The inferences reached on the ground of the results obtained are the 
following: 
1. Persisting or progressive hypozincemia in subjects wi th past history 
of vh is an unfavourable symptom, indicating a probable tendency towards 
chronification of the process in the l iver , provided a l l other causes for the 
lowering of the zinc level are ruled out. 
2. The hypozincemia is a late sign, manifested at the time when other 
symptoms occur and characteristic of the advanced stage of the disease. 
3. I n subjects wi th cured vh , there might be some decrease of zinc in 
the serum, which should not be considered as a poor prognosis. 
4. The hypozincemia in persons wi th past history of vh is an index of 
weak dynamics. 
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ИЗУЧЕНИЕ СЫВОРОТОЧНОЙ ЦИНКЕМИИ У 202 ЛИЦ 
С ПОСТГЕПАТИТНЫМИ СИНДРОМАМИ И ЗАБОЛЕВАНИЯМИ 
Л. Минков, Ал. Станчев 
Р Е З Ю М Е 
Авторы исследовали сывороточную цинкемию у 202 л и ц , переболев­
ших вирусным гепатитом в период от 0,5 до 20 лет. Содержание цинка 
определялось по дитизонному методу Регенбергера . Снижение цинкемии 
допускается при величинах ниже 109%. Исследуемые были разделены 
на группы в зависимости от состояния печени. 
Наиболее н и з к а я , намного н и ж е нормальной , цинкемия — в сред­
нем 79% была обнаружена у перенесших послегепатитные циррозы. 
Н а втором месте по снижению цинка я в л я е т с я группа страдающих хро­
ническим г е п а т и т о м — с р е д н я я величина 104%. Эти числа статистически 
достоверны в сравнении с группой выздоровевших (средняя цинкемия 
126%). В остальных трех группах —невыздоровевшие от вирусного ге­
патита, с остаточной гепатомегалией и постгепатитной гипербиллируби-
немией, средние концентрации цинка в границах нормы и статистически 
недостоверны. 
Гипоцинкемия у переболевших вирусным гепатитом, имеющих пора­
ж е н и я печени, является показателем, который по своей частоте превы­
шает некоторые обычные показатели поражения печени, а именно: гипер-
гамаглобулииемию, ж е л т у х у , спленомегалию, тимоловую пробу, гипер-
билирубинемию и пр . и уступает по частоте субъективным ж а л о б а м , 
удлиненной ленте Вельтмана , гиперуробилиногенурии и гепатомегалии. 
Ц и н к е м и я при поражении печени я в л я е т с я сравнительно поздним симп­
томом. 
